Affinity DataEC50: 0nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.0660nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.100nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.100nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.100nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.100nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.100nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.200nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.200nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.200nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.200nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.280nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.300nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.300nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.300nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.300nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.400nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.400nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.400nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.560nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...More data for this Ligand-Target Pair
Affinity DataEC50: 0.560nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
Affinity DataEC50: 0.600nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.600nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.600nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.600nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.600nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.670nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.700nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.700nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.700nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.700nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
Affinity DataEC50: 0.900nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
